Related references
Note: Only part of the references are listed.Dyslipidemia of kidney disease
Per-Ola Attman et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis
Akio Kawakami et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2009)
Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction
Akio Kawakami et al.
CIRCULATION (2008)
Apolipoprotein CIII and atherosclerosis - Beyond effects on lipid metabolism
Alex Bobik
CIRCULATION (2008)
Toll-Like Receptor 2 Mediates Apolipoprotein CIII-Induced Monocyte Activation
Akio Kawakami et al.
CIRCULATION RESEARCH (2008)
Increased plasma apolipoprotein C-III concentration independently predicts cardiovascular mortality: The Hoorn Study
Peter G. Scheffer et al.
CLINICAL CHEMISTRY (2008)
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
D. C. Chan et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Combined Effect of Hemostatic Gene Polymorphisms and the Risk of Myocardial Infarction in Patients with Advanced Coronary Atherosclerosis
Nicola Martinelli et al.
PLOS ONE (2008)
Triglycerides and the risk of coronary heart disease - 10 158 incident cases among 262 525 participants in 29 Western prospective studies
Nadeem Sarwar et al.
CIRCULATION (2007)
Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells
Akio Kawakami et al.
CIRCULATION (2006)
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute
Sidney C. Smith et al.
CIRCULATION (2006)
A cell-based model of thrombin generation
HR Roberts et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
Lipoprotein genotype and conserved pathway for exceptional longevity in humans
G Atzmon et al.
PLOS BIOLOGY (2006)
Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells
A Kawakami et al.
CIRCULATION (2006)
From vulnerable plaque to vulnerable patient - A call for new definitions and risk assessment strategies: Part I
M Naghavi et al.
CIRCULATION (2003)
Indices related to apo CII and CIII serum concentrations and coronary heart disease: a case-control study
Y Gerber et al.
PREVENTIVE MEDICINE (2003)
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders
A Onat et al.
ATHEROSCLEROSIS (2003)
LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients
SJ Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease
O Olivieri et al.
JOURNAL OF LIPID RESEARCH (2003)
ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
K Olin-Lewis et al.
JOURNAL OF LIPID RESEARCH (2002)
ApoC-III gene polymorphisms and risk of coronary artery disease
O Olivieri et al.
JOURNAL OF LIPID RESEARCH (2002)
AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update - A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
SC Smith et al.
CIRCULATION (2001)
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial
FM Sacks et al.
CIRCULATION (2000)
Share Paper
